<SEC-DOCUMENT>0001213900-23-002651-index.html : 20230113
<SEC-HEADER>0001213900-23-002651.hdr.sgml : 20230113
<ACCEPTANCE-DATETIME>20230113114742
ACCESSION NUMBER:		0001213900-23-002651
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20230113
FILED AS OF DATE:		20230113
DATE AS OF CHANGE:		20230113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Can-Fite BioPharma Ltd.
		CENTRAL INDEX KEY:			0001536196
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36203
		FILM NUMBER:		23527851

	BUSINESS ADDRESS:	
		STREET 1:		10 BAREKET STREET, KIRYAT MATALON
		STREET 2:		P.O. BOX 7537
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951778
		BUSINESS PHONE:		972 39241114

	MAIL ADDRESS:	
		STREET 1:		10 BAREKET STREET, KIRYAT MATALON
		STREET 2:		P.O. BOX 7537
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			4951778
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea171609-6k_canfitebio.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea171609-6k_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea171609ex5-1_canfitebio.htm
<DESCRIPTION>OPINION OF DORON TIKOTZKY KANTOR GUTMAN, NASS & AMIT GROSS
<TEXT>
Document 2 - file: ea171609ex5-1_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>ea171609ex5-2_canfitebio.htm
<DESCRIPTION>OPINION OF GREENBERG TRAURIG, LLP
<TEXT>
Document 3 - file: ea171609ex5-2_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea171609ex10-1_canfitebio.htm
<DESCRIPTION>FORM OF REGISTERED DIRECT OFFERING SECURITIES PURCHASE AGREEMENT, DATED JANUARY 11, 2023
<TEXT>
Document 4 - file: ea171609ex10-1_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea171609ex10-2_canfitebio.htm
<DESCRIPTION>FORM OF PIPE SECURITIES PURCHASE AGREEMENT, DATED JANUARY 11, 2023
<TEXT>
Document 5 - file: ea171609ex10-2_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ea171609ex10-3_canfitebio.htm
<DESCRIPTION>FORM OF REGISTERED DIRECT PRE-FUNDED WARRANT
<TEXT>
Document 6 - file: ea171609ex10-3_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>ea171609ex10-4_canfitebio.htm
<DESCRIPTION>FORM OF SERIES A AND SERIES B WARRANT
<TEXT>
Document 7 - file: ea171609ex10-4_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>8
<FILENAME>ea171609ex10-5_canfitebio.htm
<DESCRIPTION>FORM OF PRIVATE PLACEMENT PRE-FUNDED WARRANT
<TEXT>
Document 8 - file: ea171609ex10-5_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>9
<FILENAME>ea171609ex10-6_canfitebio.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 11, 2023
<TEXT>
Document 9 - file: ea171609ex10-6_canfitebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: ex5-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: ex5-2_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>